
Aflac (AFL) Stock Forecast & Price Target
Aflac (AFL) Analyst Ratings
Bulls say
Aflac is well-positioned for future growth with its expanding product offerings and a plan to increase the ceding rate of Japanese liabilities, freeing up capital for investment. The company has faced challenges with earnings emergence and a consistently high benefit ratio, but they remain confident in their outlook and are focused on maintaining profitability. The recent restructuring of their investment income portfolio and growth in premiums are positive indicators for the company's financial performance.
Bears say
Aflac is facing challenges in both its medical insurance product sales and its potential mergers and acquisitions. With a decline in sales in the second quarter due to product launch timing and a less aggressive sales campaign, and the need for careful evaluation of potential acquisitions, the company's financial outlook remains uncertain. Despite strong earnings, structural changes are needed to increase shareholder returns and support future business growth.
This aggregate rating is based on analysts' research of Aflac and is not a guaranteed prediction by Public.com or investment advice.
Aflac (AFL) Analyst Forecast & Price Prediction
Start investing in Aflac (AFL)
Order type
Buy in
Order amount
Est. shares
0 shares